Antisense Oligonucleotides
- 1 February 1998
- journal article
- review article
- Published by S. Karger AG in Nephron Experimental Nephrology
- Vol. 6 (1) , 84-88
- https://doi.org/10.1159/000020509
Abstract
Antisense technology was developed to inhibit gene expression by utilizing an oligonucleotide complementary to the mRNA which encodes the target gene. There are a few possible mechanisms for the inhibitory effects of antisense oligonucleotides. Among them, degradation of mRNA by RNase H is considered to be the major mechanism of action for antisense oligonucleotides. This technique was originally used to elucidate the function of a target gene, but may also have therapeutic applications, provided it is designed carefully and properly.Keywords
This publication has 2 references indexed in Scilit:
- Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferationNature, 1994
- Efficient Gene Transfer with Less Cytotoxicity by Means of Cationic Multilamellar LiposomesBiochemical and Biophysical Research Communications, 1993